Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date December 31, 2019 · Filed October 30, 2020
Section 16 reporting ended · disclosed 2020-10-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,574 |
Reported balance
After 2020-09-30 transaction · row 1
1 source rowRow 1 · 2020-09-30 · Grant · Acquired 22 · Balance 1,574 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2020 Filed Oct 30, 2020 16:42 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 22 | $74.74 | $1,644.28 |
DisclosureSEC source: 0001127602-20-027698 · form5.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Read SEC document |
| June 30, 2020 Filed Jul 8, 2020 01:23 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 24 | $68.39 | $1,641.36 |
DisclosureSEC source: 0000950123-20-006788 · doc4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,975 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 18,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · derivative · entry 7 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 18,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 23,360 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · derivative · entry 6 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,840 Underlying: Common Stock · 23,360 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 9,919 | $82.02 | $813,556.38 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 5 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,951 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.56 to $82.74. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 13,167 | $81.03 | $1,066,922.01 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 4 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,870 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 18,000 | $41.93 | $754,740.00 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 3 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 16,555 | $81.29 | $1,345,755.95 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 2 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,037 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 23,360 | $39.87 | $931,363.20 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:19 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 112 | $54.41 | $6,093.92 |
DisclosureSEC source: 0001127602-20-012802 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,232 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 20,000 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · derivative · entry 7 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-03-02 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · derivative · entry 6 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · derivative · entry 5 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 375 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 118 | $94.64 | $11,167.52 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 4 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,120 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 3 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 111 | $94.64 | $10,505.04 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 2 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,838 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009041 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 20:53 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 16 | $106.24 | $1,699.84 |
DisclosureSEC source: 0001127602-20-000592 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 19:05 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 18 | $91.34 | $1,644.12 |
DisclosureSEC source: 0001127602-19-029663 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,558 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 16:25 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 20 | $81.29 | $1,625.80 |
DisclosureSEC source: 0001127602-19-023376 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540 Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:54 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 74 | $79.02 | $5,847.48 |
DisclosureSEC source: 0001127602-19-014216 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009960 · form4.xml · derivative · entry 7 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009960 · form4.xml · derivative · entry 6 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Underlying: Common Stock · 375 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:55 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 24,000 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-19-009960 · form4.xml · derivative · entry 5 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2029-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 139 | $78.76 | $10,947.64 |
DisclosureSEC source: 0001127602-19-009960 · form4.xml · nonDerivative · entry 4 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009960 · form4.xml · nonDerivative · entry 3 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 131 | $78.76 | $10,317.56 |
DisclosureSEC source: 0001127602-19-009960 · form4.xml · nonDerivative · entry 2 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,185 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009960 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 19:38 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 26 | $60.99 | $1,585.74 |
DisclosureSEC source: 0001127602-19-000561 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 941 Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 21:01 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 22 | $75.26 | $1,655.72 |
DisclosureSEC source: 0001127602-18-028789 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915 Read SEC document |
| June 29, 2018 Filed Jul 2, 2018 15:57 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 24 | $69.54 | $1,668.96 |
DisclosureSEC source: 0001127602-18-022086 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 893 Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 18:46 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 66 | $60.16 | $3,970.56 |
DisclosureSEC source: 0001127602-18-013609 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 869 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010124 · form4.xml · derivative · entry 7 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 400 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010124 · form4.xml · derivative · entry 6 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 375 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 26,000 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-18-010124 · form4.xml · derivative · entry 5 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires 2028-03-01 F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 139 | $59.96 | $8,334.44 |
DisclosureSEC source: 0001127602-18-010124 · form4.xml · nonDerivative · entry 4 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 803 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010124 · form4.xml · nonDerivative · entry 3 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 131 | $59.96 | $7,854.76 |
DisclosureSEC source: 0001127602-18-010124 · form4.xml · nonDerivative · entry 2 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 542 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010124 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 17:33 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 33 | $48.42 | $1,597.86 |
DisclosureSEC source: 0001127602-18-000042 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298 Read SEC document |
| October 02, 2017 Filed Oct 2, 2017 17:53 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 32 | $49.85 | $1,595.20 |
DisclosureSEC source: 0001127602-17-028561 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009996 · form4.xml · derivative · entry 5 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2027-03-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 30,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-17-009996 · form4.xml · derivative · entry 4 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-03-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009996 · form4.xml · derivative · entry 3 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 Underlying: Common Stock · 375 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:40 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 142 | $41.93 | $5,954.06 |
DisclosureSEC source: 0001127602-17-009996 · form4.xml · nonDerivative · entry 2 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 18:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009996 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.